These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 5668416

  • 1. [A contribution to the biochemical treatment of the akinetic type of the Parkinson's syndrome].
    Völler GW.
    Med Welt; 1968 Feb 03; 5():338-41. PubMed ID: 5668416
    [No Abstract] [Full Text] [Related]

  • 2. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W.
    Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug therapy of parkinsonism.
    Yahr MD, Duvoisin RC.
    N Engl J Med; 1972 Jul 06; 287(1):20-4. PubMed ID: 4555145
    [No Abstract] [Full Text] [Related]

  • 5. [On the treatment of Parkinson's syndrome with monoamine oxidase inhibitors alone and in combination with L-dopa].
    Gerstenbrand F, Prosenz P.
    Praxis; 1965 Nov 18; 54(46):1373-7. PubMed ID: 5899418
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C, Schumacher HC, Burgut FT.
    Expert Rev Neurother; 2005 Nov 18; 5(6):811-21. PubMed ID: 16274338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ, Swope DM, Dashtipour K.
    Clin Ther; 2007 Sep 18; 29(9):1825-49. PubMed ID: 18035186
    [Abstract] [Full Text] [Related]

  • 19. MAO-B inhibitors for the treatment of Parkinson's disease.
    Mov Disord; 2002 Sep 18; 17 Suppl 4():S38-44. PubMed ID: 12211138
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.